Six out of 31 total new small molecules approved by the FDA in 2024 were produced by Wuxi, said the company's co-CEO.

The governor also said she would work with other states to leverage their combined purchasing power to reduce the cost of the ...

But, no matter what direction the general market takes, some stocks could stand out, potentially in 2025, and most ...

LONDON: Doctors worldwide should diagnose obesity differently, relying on broader criteria and taking into account when the condition causes ill-health, according to a new framework drawn up by ...

An international group of experts proposes two new categories of disease: preclinical and clinical obesity and the FDA ...

But now that these drugs are in greater demand from both patients and doctors, state Medicaid programs are grappling with whether to cover them for weight loss, both for reasons of equity and to save ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Dr Daniel Rosen, who is a surgeon and obesity medicine specialist based out of New York, says a 'legitimate number' of his ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 465.16% and ...

The just-published findings reveal what regulates a gene that’s pivotal to our food intake - and also our risk of obesity.

The new proposal is the result of three years of research by FDA scientists, who studied similar front-of-package labeling ...

Using body-mass index to tell who is overweight or obese is not reliable and can result in misdiagnosis, the Commission on ...